Status:
COMPLETED
Evaluation of Anti-venoms Serum in Africa
Lead Sponsor:
Institut Pasteur
Collaborating Sponsors:
Cameroon Society of Epidemiology (CaSE)
Centre International de Recherches d'Enseignements et de Soins (CIRES)
Conditions:
Snake Bites
Antivenins
Eligibility:
All Genders
5+ years
Brief Summary
There is little or no assessment under real-use conditions of the efficacy and the tolerance in the short, medium and long term of the antivenoms currently on the market and used in the treatment of s...
Detailed Description
Globally, the number of annual envenomings is estimated to be between 420,000 and 1,800,000. In sub-Saharan Africa, the annual number of envenomings is estimated at 315,000, leading to more than 9,000...
Eligibility Criteria
Inclusion
- Any patient over 5 years old (inclusive) visiting at a participating center for a snake bite with or without confirmed envenoming
- Informed consent to research
Exclusion
- Patient refusal
- Under 5 year-old
- Antivenom serum administration before the arrival in the participating center
- History of severe allergic reactions to antivenom serum
Key Trial Info
Start Date :
October 17 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 14 2021
Estimated Enrollment :
474 Patients enrolled
Trial Details
Trial ID
NCT03326492
Start Date
October 17 2019
End Date
September 14 2021
Last Update
September 22 2025
Active Locations (13)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital de District d'Akonolinga
Akonolinga, Cameroon
2
Hôpital régional de Buea
Buea, Cameroon
3
Hôpital de District de Guider
Guider, Cameroon
4
Hôpital de District de Kolofata
Kolofata, Cameroon